Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
| Autor: | Craig, S, Kohler, M, Ayers, L, Nunn, A, Bratton, D |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| DOI: | 10.1136/thoraxjnl-2014-205958 |
| Popis: | The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6 months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values >0.13).ISRCTN 34164388. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|